NCT02348359 - X-82 to Treat Age-related Macular Degeneration | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

March 16, 2015

Primary Completion Date

December 12, 2017

Study Completion Date

January 12, 2018

Conditions

Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular DegenerationAMDMacular Degeneration, Age-related, 10Eye DiseasesRetinal DegenerationRetinal Diseases

Interventions

DRUG

X-82

DRUG

Anti-VEGF

DRUG

Placebo

Trial Locations (35)

Unknown

Tucson

Beverly Hills

Huntington Beach

Redlands

Sacramento

Colorado Springs

Golden

New London

Fort Myers

Lakeland

Melbourne

Miami

Palm Beach Gardens

Augusta

Lemont

Oak Forest

Indianapolis

Baltimore

Glen Burnie

Boston

Springfield

Portsmouth

Bloomfield

Albany

New York

Asheville

Charlotte

Cleveland

Youngstown

Nashville

Abilene

Austin

Houston

The Woodlands

Richmond